BerandaINO • NASDAQ
add
Inovio Pharmaceuticals Inc
Tutup sebelumnya
$1,33
Rentang hari
$1,33 - $1,37
Rentang tahun
$1,30 - $12,33
Kapitalisasi pasar
69,56 jt USD
Volume Rata-Rata
1,84 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 65,34 rb | — |
Biaya operasional | 9,02 jt | -14,63% |
Laba bersih | -19,69 jt | 35,36% |
Margin laba bersih | -30,14 rb | — |
Penghasilan per saham | -0,51 | 61,07% |
EBITDA | -24,68 jt | 20,54% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 68,36 jt | -35,27% |
Total aset | 87,27 jt | -32,41% |
Total liabilitas | 36,02 jt | 3,89% |
Total ekuitas | 51,25 jt | — |
Saham yang beredar | 36,67 jt | — |
Harga terhadap nilai buku | 0,95 | — |
Tingkat pengembalian aset | -62,48% | — |
Tingkat pengembalian modal | -87,66% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,69 jt | 35,36% |
Kas dari operasi | -26,87 jt | 6,56% |
Kas dari investasi | -51,75 rb | -100,11% |
Kas dari pembiayaan | 1,03 jt | 109,05% |
Perubahan kas bersih | -25,90 jt | -589,47% |
Arus kas bebas | -21,47 jt | -26,75% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Situs
Karyawan
134
